Toward a human vaccines project

Nature Immunology

Volumn 15, Issue 7, 2014, Pages 589-592

  Koff, Wayne C ^a   Gust, Ian D ^b   Plotkin, Stanley A ^c,d  

^a INTERNATIONAL AIDS VACCINE INITIATIVE   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Vaxconsult   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR; VACCINE; VIRUS VACCINE;

ADAPTIVE IMMUNITY; ALLERGY; ALPHA VIRUS; ALZHEIMER DISEASE; AMINO ACID DEFICIENCY; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BIOINFORMATICS; BIOLOGY; CELLULAR IMMUNITY; CLINICAL RESEARCH; CLINICAL STUDY; CYTOMEGALOVIRUS; DEFECTIVE VIRUS; GENE SEQUENCE; GENOMICS; HISTOCOMPATIBILITY COMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOLOGICAL MONITORING; INFECTION; INFLUENZA VIRUS; MALIGNANT NEOPLASTIC DISEASE; MASS SPECTROMETRY; MICROBIOME; NEISSERIA MENINGITIDIS; NONHUMAN; NOTE; POPULATION SIZE; PREVENTION AND CONTROL; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; REPLICON; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SYNTHETIC BIOLOGY; SYSTEMS BIOLOGY; T LYMPHOCYTE; UNITED STATES; YELLOW FEVER; DENGUE; GENETIC VARIABILITY; HEPATITIS C VIRUS; IMMATURITY; LIVER CANCER; MALARIA; MEMORY T LYMPHOCYTE; MUMPS; PERTUSSIS; SOMATIC HYPERMUTATION; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS;

HUMANS; VACCINES;

EID: 84902689538     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2871     Document Type: Note

References (29)

1. Centers for Disease Control and Prevention. MMWR Morb. Mortal. Wkly. Rep. 48, 621-629 (1999).
2. US Food and Drug Administration. Vaccines, Blood & Biologics. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM093833 (2013).
3. Nabel, G.J. N. Engl. J. Med. 368, 551-560 (2013).
4. Wendelboe, A.M., Van Rie, A., Salmaso, S. & Englund, J.A. Pediatr. Infect. Dis. J. 24, S58-S61 (2005).
5. Anderson, L.J. et al. Vaccine 31, B209-B215 (2013).
6. Lang, P.O. et al. Curr. Top. Med. Chem. 13, 2541-2550 (2013).
7. Wood, N. & Siegrist, C.A. Curr. Opin. Infect. Dis. 24, 190-195 (2011).
8. Chan, J. et al. Vaccine 29, 1242-1247 (2011).
9. Greenwood, B.M. & Targett, G.A. Clin. Microbiol. Infect. 17, 1600-1607 (2011).
10. Marinova, D., Gonzalo-Asensio, J., Aguilo, N. & Martin, C. Expert Rev. Vaccines 12, 1431-1448 (2013).
11. Wenxue, M. Curr. Med. Chem. (5 February 2014).
12. Koff, W.C. et al. Science 340, 1232910 (2013).
13. Sette, A. & Rappuoli, R. Immunity 33, 530-541 (2010).
14. Burton, D.R., Poignard, P., Stanfield, R.L. & Wilson, I.A. Science 337, 183-186 (2012).
15. Correia, B.E. et al. Nature 507, 201-206 (2014).
16. Haynes, B.F., Kelsoe, G., Harrison, S.C. & Kepler, T.B. Nat. Biotechnol. 30, 423-433 (2012).
17. Kwong, P.D., Mascola, J.R. & Nabel, G.J. Nat. Rev. Immunol. 13, 693-701 (2013).
18. McLellan, J.S. et al. Science 342, 592-598 (2013).
19. Geall, A.J. et al. Proc. Natl. Acad. Sci. USA 109, 14604-14609 (2012).
20. Hansen, S.G. et al. Nature 473, 523-527 (2011).
21. Parks, C.L., Picker, L.J. & King, C.R. Curr Opin HIV AIDS 8, 401-410 (2013).
22. Reinhold, B., Keskin, D.B. & Reinherz, E.L. Anal. Chem. 82, 9090-9099 (2010).
23. Querec, T.D. et al. Nat. Immunol. 10, 116-125 (2009).
24. Ravindran, R. et al. Science 343, 313-317 (2014).
25. Li, S. et al. Nat. Immunol. 15, 195-204 (2014).
26. Corti, D. & Lanzavecchia, A. Annu. Rev. Immunol. 31, 705-742 (2013).
27. Liao, H.X. et al. Nature 496, 469-476 (2013).
28. Wu, X. et al. Science 333, 1593-1602 (2011).
29. Newell, E.W., Sigal, N., Bendall, S.C., Nolan, G.P. & Davis, M.M. Immunity 36, 142-152 (2012).